Page 1 of Clinical Trials for Anadys Pharmaceuticals [SPONSOR-COLLABORATORS], 4 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Active, not recruiting
Safety and Efficacy of ANA598 Administered With Pegylated Interferon and Ribavirin in Genotype-1 Patients With Chronic HCV Infection
Last Updated: August 3, 2011
Condition(s): Hepatitis C
2
Completed
Study of ANA773 in Healthy Volunteers and Patients With Hepatitis C Virus (HCV) to Assess Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)
Last Updated: September 28, 2010
Condition(s): HCV Infection
3
Completed
Safety, Tolerability, and Antiviral Activity of ANA598 in Patients With Genotype-1 Chronic HCV Infection
Last Updated: May 27, 2011
Condition(s): Chronic Hepatitis C
4
Completed
Safety, Tolerability, and Antiviral Activity of ANA598 Administered in Combination With Pegylated Interferon and Ribavirin for the Treatment of Genotype-1 Chronic HCV Infection
Last Updated: January 30, 2012
Condition(s): HCV Infection

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Anadys+Pharmaceuticals

Page 1 of Clinical Trials for Anadys Pharmaceuticals [SPONSOR-COLLABORATORS], 4 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About